The amplitude, polyphasic changes, and the proximal and distal CMAP latencies were recorded, and the nerve conduction velocity was calculated according to previous studies [41, 43]
Turkey 17.6
42 The mechanisms of these complex effects are still being elucidated, and it is unclear whether there is a direct effect via GLP-1 receptors in bone cells or indirect effects mediated through the gut
Neurological Health BPC-157 is also evidenced to have neuroprotective effects, reducing nerve damage due to strokes and injuries while regulating neurotransmitters to attenuate symptoms of Parkinsons disease, schizophrenia, and depression [2, 33, 36]
On-Label vs Off-Label Use and Regulatory Considerations Because BPC-157 is not approved by the FDA for any indication, any human use is off-label or within research settings
Storage requirements Proper storage preserves peptide potency